Table 1 Clinicopathologic factors of BC patients
Patients’ clinical characteristics | n |
|---|---|
Age (years) mean 55.6 | |
<50 | 6 |
>50 | 11 |
TNM (stage) | |
1 | 1 |
2 | 10 |
3 | 6 |
Clinical stage | |
IIA | 2 |
IIB | 8 |
IIIA | 6 |
IIIB | 1 |
Clinical Lymph Node Classification | |
cN0 | 3 |
cN1 | 10 |
cN2 | 4 |
cN3 | 0 |
Systemic metastases | |
No | 17 |
Yes | 0 |
Residual Cancer Burden (RCB)* | |
RCB-III | 0 |
RCB-II | 11 |
RCB-I | 2 |
pCR | 4 |
Estrogen receptor (ER) | |
Positive (>10%) | 13 |
Negative (<10%) | 4 |
Progesterone receptor (PR) | |
Positive (>10%) | 10 |
Negative (<10%) | 7 |
Ki-67 | |
Positive (>14%) | 4 |
Negative (<14%) | 13 |
Her2/neu | |
Positive | 5 |
Negative | 12 |
Scarff-Bloom-Richardson (SBR) grade | |
I | 0 |
II | 10 |
III | 7 |
Breast Cancer sub-types** | |
Luminal A | 3 |
Luminal B | 10 |
Triple negative | 3 |
Her2/neu overexpressing | 1 |